The BCR/ABL P210 fusion gene was negative, the BCR/ABL P190 fusion gene was negative, and the BCR/ABL P230 fusion gene was positive, confirming the diagnosis of e19a2-positive CML. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.